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Previous studies have shown that passage of nonpathogenic SHIV-4 through a series of macaques results in the selection
of variants of the virus that are capable of causing rapid subtotal loss of CD41 T cells and AIDS within 6–8 months following
inoculation into pig-tailed macaques. Using a pathogenic variant of SHIV-4 known as SHIVKU-1bMC33, we reported that a mutant
of this virus with the majority of the vpu deleted was still capable of causing profound CD41 T cell loss and neuroAIDS in
pig-tailed macaques (McCormick-Davis et al., 2000, Virology 272, 112–116). In this study, we have analyzed the tissue-specific
changes in the env and nef in one macaque that developed neuroAIDS (macaque 50 O) and in three macaques that developed
only a moderate or no significant loss of CD41 T cells and no neurological disease (macaques 50 Y, 20220, 20228) following
inoculation with DvpuSHIVKU-1bMC33. Sequence analysis of the gp120 region of env isolated from lymphoid tissues (lymph node
and spleen) of macaques 50 Y, 20220, and 20228 revealed no consensus amino acid substitutions. In contrast, analysis of
the gp120 sequences isolated from lymphoid and CNS tissues (parietal cortex, basal ganglia, and pons) of macaque 50 O
revealed numerous amino acid substitutions. The significance of the amino acid substitutions in gp120 was supported by
neutralization assays which showed that the virus isolated from the lymph node of macaque 50 O was neutralization resistant
compared to the parental SHIVKU-1bMC33. Analysis of changes in the nef gene from macaque 50 O revealed in-frame deletions
in Nef that ranged from 4 to 13 amino acids in length, whereas the nef genes isolated from the other three macaques revealed
no deletions or consensus amino acid substitutions. Inoculation of the virus isolated from the lymph node of the macaque
which developed neuroAIDS, SHIV50OLNV, into four pig-tailed macaques resulted in a severe loss of the circulating CD4
1 T cells
within 2 weeks postinoculation, which was maintained for up to 20 weeks postinoculation, confirming that this virus had
indeed become more pathogenic in pig-tailed macaques. Taken together, these observations suggest that DvpuSHIVKU-1bMC33
has a low pathogenic phenotype in macaques but that individual pig-tailed macaques can select for additional mutations
within the Env and Nef which can compensate for the lack of an intact Vpu and ultimately increase its pathogenicity. © 2001
Academic Press
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The development of pathogenic simian-human immu-
nodeficiency viruses (SHIV) containing the tat, rev, vpu,
and env of HIV-1 in a genetic background of SIVmac239
has permitted analysis of the role of HIV-1-specific gene
products in a pathogenic macaque model. Pathogenic
SHIVs expressing the envelope glycoproteins from
T-tropic or dualtropic isolates of HIV-1 have now been
developed in several laboratories (Joag et al., 1996;
Reiman et al., 1996; Shibata et al., 1997; Joag et al., 1998;
Harouse et al., 1999; Luciw et al., 1999). Macaques inoc-
ulated with these pathogenic SHIVs generally develop a
rapid decline in the number of circulating CD41 T cells,
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123ncreased susceptibility to opportunistic infections, and
enerally succumb to their infections with 6–8 months
Joag et al., 1997). In addition to the severe immune
ysfunction, some pathogenic SHIVs also cause other
linical syndromes such as neurological disease that is
haracterized by perivascular cuffing, microglial nodules,
iant cells, and demyelination (Raghavan et al., 1997; Liu
et al., 1999; McCormick-Davis et al., 2000) and a ne-
phropathy that is characterized by glomerulosclerosis,
elevated serum urea nitrogen levels, and microprotein-
uria (Liu et al., 1999; Stephens et al., 2000).
Recently, we reported that a SHIV containing a trun-
cated, nonmembrane-bound Vpu (DvpuSHIVKU-1bMC33) was
still capable of causing a rapid decline in the circulating
CD41 T cells and neuroAIDS following inoculation intoig-tailed macaques (McCormick-Davis et al., 2000). Be-
ause previous studies had shown that following inocu-
0042-6822/01 $35.00
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124 SINGH ET AL.lation with the parental SHIVKU-1 and SHIVKU-1b, pig-tailed
macaques developed severe CD41 T cell loss in the
bsence of neurological disease (Raghavan et al., 1997;
Narayan et al., 1999), it suggested that the virus in this
macaque may have evolved genotypic and phenotypic
properties that differed from the parental virus used to
inoculate these macaques. In this report, we have ana-
lyzed the sequence changes in the tat, rev, vpu, env, and
nef regions in one macaque that developed neuroAIDS
and have compared the phenotypic characteristics to the
viruses recovered from other macaques that developed
low or moderate CD41 T cell loss without neuroAIDS.
ur results indicate that the Env protein of this virus from
he macaque that developed neuroAIDS has accumu-
ated significant amino acid substitutions and small in-
rame deletions in the gp120 region that probably ac-
ounted for its neutralization-resistant phenotype. Per-
aps more interesting was that in certain regions of the
NS, the majority of the amino acid substitutions in the
p120 were reversions to the parental T-tropic HXB2
nvelope glycoprotein, suggesting that the input env of
his dualtropic env had evolved toward a T-tropic pheno-
ype. Since previous studies have shown that infecting
-tropic HIV-1 can evolve toward a T-tropic phenotype
uring later stages of the disease, this study further
hows the utility of the SHIV/macaque model in studying
scape variants of Env.
RESULTS
D41 T cell counts and virus burdens in macaques
noculated with DvpuSHIVKU-1bMC33
We previously reported on the circulating CD41 T cell
evels and virus burdens in two macaques (50 O and 50
) that were inoculated with DvpuSHIVKU-1bMC33 (McCor-
mic-Davis et al., 2000). We have since inoculated two
additional macaques with this virus (20220 and 20228).
The circulating CD41 T cells counts and virus burdens
are shown in Fig. 1. Both macaques 20220 and 20228
had initial bursts of virus replication. Virus was intermit-
tently recovered from macaque 20220 and virus was
recovered from macaque 20228 throughout the course of
its infection. The circulating CD41 T cell counts in these
two macaques were stable throughout the course of the
7-month study.
Rationale for sequence analysis
In previous studies, pig-tailed macaques inoculated
with pathogenic variants of SHIV-4 (SHIVKU-1, SHIVKU-1b)
did not develop SHIV-associated neurologic disease
(Raghavan et al., 1997; Narayan et al., 1999). Thus, when
a pig-tailed macaque 50 O developed severe CD41 T cell
oss and SHIV-associated encephalitis following inocu-
ation with a variant of this virus (DvpuSHIVKU-1bMC33), it
uggested that amino acid changes had occurred in thisirus that were not seen in previously derived pathogenic
HIVs. In addition, our previous studies suggested that
he most amino acid substitutions were observed in the
nv and nef genes of the virus. Therefore, we concen-
trated on the analysis of changes that occurred in the env
and nef genes isolated from two lymphoid tissues
(spleen and lymph node) and three regions of the CNS
(pons, basal ganglia, and occipital cortex). As expected,
sequence analysis revealed that the large deletion within
the vpu region from macaque 50 O, 50 Y, 20220, and
20228, which reflected the deletion in the original
DvpuSHIVKU-1bMC33 used to inoculate these macaques,
was maintained throughout the course of infection (Fig.
1). No other changes were detected in the truncated vpu
when compared to the input DvpuSHIVKU-1bMC33 virus.
The nef gene of the virus isolated from macaque 50
O contains a series of in-frame deletions
We next analyzed the sequence of the nef genes
amplified from the same tissues from the four macaques.
As shown in Fig. 2, the nef genes amplified from the
various tissues of macaque 50 O had two consensus
amino acid changes. A threonine to alanine at position
110 (in 17 of 25 clones analyzed) and an alanine to
threonine at position 185 (19 of 25 clones analyzed). Most
interesting, however, was the finding that 72% of the nef
genes isolated (18 of 25 clones analyzed) from macaque
50 O had in-frame deletions in nef. These deletions were
between amino acid residues 37 and 55 and varied from
4 to 13 amino acids in length. Of these deletions found in
the nef clones, the 4 amino acid deletion found at posi-
tion 45–48 was the most prominent (16 of 18 clones with
deletions). In contrast, the amplified nef genes isolated
from the spleen and lymph node of macaque 50 Y, 20220,
or 20228 revealed neither any consensus amino acid
substitutions nor any deletions (data not shown).
The deletions in nef occurred following the severe
depletion of CD41 T cells in macaque 50 O
Because in previous studies we had observed amino
acid substitutions in Nef, but never any Nef deletions
during the pathogenic adaptation of SHIV-4 to cause
disease in pig-tailed and rhesus macaques, we deter-
mined when this deletion first appeared following inoc-
ulation with DvpuSHIVKU-1bMC33. This was accomplished by
solating DNA from PBMC obtained at different times
fter inoculation (1, 2, and 3 months) and amplification of
he region the nef gene by PCR followed by sequence
nalysis. As shown in Fig. 3, we first observed the dele-
ions in this region of nef at 2 months postinoculation.
ince the severe CD41 T cell depletion had occurred in
macaque 50 O prior to this time point, it indicated that the
1CD4 T cell loss was not associated with the appear-
ance of the deletions in nef.
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125GENOTYPIC AND PHENOTYPIC CHARACTERIZATION AND NEUROPATHOGENIC SHIVMacaque 50 O selected for significant amino acid
substitutions in the Env
Because the clinical course of disease in macaque 50
O was much different from macaques 50 Y, 20220, and
20228 (severe CD41 T cell loss/neuroAIDS versus mod-
rate to no CD41 T cell loss) following inoculation with
DvpuSHIVKU-1bMC33, it suggested that these macaques may
have selected for different viral gp120 variants. We ex-
amined the viral gp120 sequences from two lymphoid
tissues (spleen and lymph node) and three regions of the
CNS (parietal cortex, basal ganglia, and pons) by PCR
amplification, cloning, and sequence analysis. These re-
sults shown in Fig. 4 and Table 1 indicate that the
percentage of amino acid substitutions in the gp120
FIG. 1. The levels of CD41 T cells (A) and numbers of cells produc
inoculation with DvpuSHIVKU-1bMC33.compared to the input DvpuSHIVKU-1bMC33 in various 50 O
issues varied from 3.3% in the basal ganglia to 1.4% inhe spleen and pons. When compared to the parental
HIV-4 (HXB2) Env, the consensus lymph node and
pleen sequences had a 6.7 and 4.7% change in the
mino acid sequence versus 3.7% for the gp120 of
vpuSHIVKU-1bMC33. When we compared the consensus
gp120 sequences from three regions of the CNS (parietal
cortex, basal ganglia, and pons) we found that the gp120
sequences from these regions also had a signifi-
cant number of amino acid substitutions varying from
7 substitutions (1.4% change from DvpuSHIVKU-1bMC33)
in the pons to 18 substitutions (3.3% change from
DvpuSHIVKU-1bMC33) in the basal ganglia. Our analysis of
the gp120 sequences from the CNS revealed that of the
13 consensus amino acid substitutions in the gp120 of
ctious virus (B) in macaques 50 O, 50 Y, 20220, and 20228 followingthe parietal cortex, 8 of these substitutions (61.5%) were
reversions to the HXB2 sequence of SHIV-4. Amino acid
126 SINGH ET AL.FIG. 2. Comparison of the consensus amino acid sequence of Nef from molecularly cloned DvpuSHIVKU-1bMC33, and clones isolated from the lymph
node (LN), spleen (SP), parietal cortex (PC), basal ganglia (BG), and pons (PONS) from macaque 50 O, 50 Y, 20220, and 20228. Shown above the
sequences is the sequence of SIVmac239 Nef (Regier and Desrosiers, 1990) with Nef corrected at codon 92. Dashes (—) represent amino acid identity
and (x) represent deletions.
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127GENOTYPIC AND PHENOTYPIC CHARACTERIZATION AND NEUROPATHOGENIC SHIVreversions were also observed in the lymph node,
spleen, and basal ganglia (2 each; Table 1). In contrast,
our results indicate that the gp120 sequences isolated
from macaque 50 Y, 20220, and 20228 had no consensus
amino acid substitutions or deletions (summarized in
Table 1). Thus, when compared to the Env of the original
nonpathogenic SHIV-4, lymphoid tissues appeared to be
evolving away from the parental SHIV-4 sequence
whereas in other tissues (i.e., the parietal cortex of the
CNS) appeared to be reverting back to the original
SHIV-4 sequence.
The virus isolated from the lymph node of macaque
50 O was antibody neutralization resistant compared
to the parental virus
Because the predicted amino acid sequences of the
gp120 genes isolated from macaque 50 O were divergent
from the parental DvpuSHIVKU-1bMC33, we examined the
neutralization properties of SHIV-4, DvpuSHIVKU-1bMC33,
nd the virus recovered from lymph node cells isolated
rom macaque 50 O (SHIV50OLNV). In order to more easily
nalyze the neutralization properties of the viruses with
ifferent envelope glycoproteins, we developed SHIV
ectors (with the SHIV-4, SHIVKU-1bMC33, and SHIV50OLNV
gp160) that stably expressed the enhanced green
fluorescent protein (EGFP). Plasma obtained from ma-
FIG. 2caque 50 O at necropsy was found to neutralize
DvpuSHIVKU-1bMC33 at a dilution of 1:64, suggesting that theantibodies in this plasma effectively neutralized the pa-
rental virus used to inoculate these macaques. Plasma
samples from macaques 50 Y, 20220, and 20228 were
able to neutralize DvpuSHIVKU-1bMC33 at dilutions that
ranged from 1:8 to 1:64. These same plasmas failed to
effectively neutralize (titer of #2) the infectivity of virus
isolated from the lymph node of macaque 50 O
(SHIV50OLNV). The positive control plasma used in these
tudies, a plasma pool from several macaques that had
ong-term infections with SHIV, was found to neutralize
HIV-4 and DvpuSHIVKU-1bMC33 at a dilution of 1:64 and
SHIV50OLNV at a dilution of 1:128 (Table 2). Taken together,
these results indicate that macaque 50 O had selected
for a virus (SHIV50OLNV) that was resistant to neutralization
y plasmas isolated at necropsy from all four macaques
noculated with DvpuSHIVKU-1bMC33 and thus has the phe-
otype of an antibody neutralization escape virus.
he SHIV50OLNV enters and replicates in cells with
kinetics similar to DvpuSHIVKU-1bMC33 and has retained
XCR4 coreceptor usage
Stocks of SHIV-4, SHIVKU-1bMC33, DvpuSHIVKU-1bMC33, and
HIV50OLNV were prepared and titered in C8166 cells.
Equal amounts of virus were used to inoculate C8166
cultures and assessed for virus replication by assaying
culture supernatants for the presence p27 antigen. Our
inuedresults indicate that SHIV50OLNV and DvpuSHIVKU-1bMC33 rep-
licated with similar kinetics in C8166 cells (data not
t
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128 SINGH ET AL.shown). We examined whether the SHIV50OLNV virus used
he same coreceptor(s) for entry as the virus used to
noculate macaque 50 O (DvpuSHIVKU-1bMC33). The results
shown in Table 3 indicate that SHIV-4, SHIVKU-1bMC33,
vpuSHIVKU-1bMC33, and SHIV50OLNV all used CXCR4 as their
oreceptor for entry. We also determined if the kinetics
FIG. 3. Comparison of the consensus amino acid sequence of Nef fro
of macaque 50 O at 1, 2, and 3 months after inoculation with DvpuSHIVK
nd Desrosiers, 1990) with Nef corrected at codon 92.f virus entry into cells expressing CD4 and CXCR4
as different among the four viruses. In this assay,
w
wHOST-CD4 cells expressing CXCR4 coreceptors
ere infected with various SHIVs (SHIV-4, SHIVKU-1bMC33,
vpuSHIVKU-1bMC33, SHIV50OLNV) for various periods of
time, and the number of fluorescent cells was deter-
mined at 48 h. As shown in Fig. 5, DvpuSHIVKU-1bMC33,
SHIV50OLNV, and SHIVKU-1bMC33 infected GHOST/X4 cells
ecular clone DvpuSHIVKU-1bMC33, and nef clones isolated from the PBMC
Shown above the sequences is the sequence of SIVmac239 Nef (Regierm molith approximately the same kinetics (i.e., the slopes
ere approximately the same) while the SHIV-4 virus
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129GENOTYPIC AND PHENOTYPIC CHARACTERIZATION AND NEUROPATHOGENIC SHIVinfected the same cell type at a somewhat slower rate.
These results indicate that while all three of the patho-
genic SHIVs were more efficient at infecting cells than
nonpathogenic SHIV-4, significant differences were
not observed in the efficiency of infection by the three
pathogenic SHIVs examined. Taken together, these
results suggest that the virus isolated from the lymph
node of macaque 50 O did not bind and enter cells at
a faster rate than the parental DvpuSHIVKU-1bMC33, and
tilized the same coreceptor for entry.
HIV50OLNV causes severe CD4
1 T cell depletion in
ig-tailed macaques
We determined if the virus derived from the lymph
ode of 50 O (SHIV50OLNV) was capable of causing the
evere CD41 T cell loss following inoculation into pig-
ailed macaques. Four macaques were inoculated intra-
enously with 104 TCID50 of SHIV50OLNV and followed for 20
eeks. As shown in Fig. 6A, all four macaques devel-
ped a severe loss in CD41 T cells within 2 weeks (38 to
52 circulating CD41 T cells/ml). This was followed by a
transient rebound in the CD41 T cell numbers at 4
eeks, and then a sustained loss of circulating CD41 T
cells that has been maintained for up to 20 weeks post-
inoculation in three of four macaques. The massive loss
of CD41 T cells was accompanied by high numbers of
D41 T cells producing infectious, cytopathic virus
throughout the 20-week period (Fig. 6B), which is typi-
cally observed for pig-tailed macaques inoculated with
pathogenic SHIVs (Joag et al., 1997). These results indi-
FIG. 3cate that SHIV50OLNV is more pathogenic for pig-tailed
acaques than the parental DvpuSHIVKU-1bMC33.DISCUSSION
In our previous studies on the evolution of the env from
he parental nonpathogenic SHIV-4 (containing the
-tropic HXB2 env sequence) we have shown that this
virus evolved from a T-tropic virus to one that was dual-
tropic, capable of replicating both in macaque macro-
phage cultures and in established T cell lines (Stephens
et al., 1996, 1997; Narayan et al., 1999; Liu et al., 1999). In
a time course study that analyzed the molecular changes
in the vpu, env, and nef as the virus became pathogenic
for pig-tailed macaques, there was an association be-
tween reversion of the vpu to a functional open read-
ing frame and increased amino acid substitutions in
Env and Nef (McCormick-Davis et al., 1998). This sug-
gested that the Vpu protein may have a role in the
SHIV-induced CD41 T cell loss observed in these
pig-tailed macaques. To test this hypothesis, we con-
structed a SHIV (DvpuSHIVKU-1bMC33) in which the major-
ty of the vpu was deleted (McCormick-Davis et al.,
000). When inoculated into macaques, we observed
hat one of four macaques (macaque 50 O) developed
severe loss in its circulating CD41 T cells and
neuroAIDS. This suggested that this macaque may
have selected for additional changes in the virus ge-
nome that accounted for its pathogenic phenotype.
The results in this study indicate that macaques inoc-
ulated with DvpuSHIVKU-1bMC33 (50 Y, 22020, and 22028),
which developed only moderate or no significant CD41
T cell loss during a 8-month infection, selected for
inuedminimal amino acid substitutions in the gp120 region
of Env and Nef when compared to the parental
n
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130 SINGH ET AL.FIG. 4. Comparison of the consensus amino acid sequence of gp120 from molecular clone DvpuSHIVKU-1bMC33, and clones isolated from the lymph
ode (LN), spleen (SP), parietal cortex (PC), basal ganglia (BG), and pons (PONS) clones isolated from macaque 50 O, 50 Y, 20220, and 20228. Shown
bove the sequences is the sequence of HXB2 gp160. Dashes (—) represent amino acid identity and (x) represent deletions. For comparative
urposes, brackets corresponding to the variable regions V1, V2, V3, V4, and V5 were placed above the gp120 sequences.
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131GENOTYPIC AND PHENOTYPIC CHARACTERIZATION AND NEUROPATHOGENIC SHIVDvpuSHIVKU-1bMC33. The fact that macaque 50 Y devel-
1
FIG. 4oped a moderate loss of CD4 T cells suggests that
the DvpuSHIVKU-1bMC33 virus, despite the lack of a func-
l
fional Vpu, was still capable of causing CD41 T cell
inuedoss. In contrast, analysis of the gp120 sequences
rom the one macaque that developed severe CD41 T
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132 SINGH ET AL.cell loss and neuroAIDS revealed the accumulation of
FIG. 4significant numbers of amino acid substitutions when
compared to parental DvpuSHIVKU-1bMC33. The percent-age of amino acid substitutions in gp120 genes iso-
inuedlated from the lymph node had increased from 3.7% in
DvpuSHIVKU-1bMC33 to 6.7% at necropsy in macaque 50
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133GENOTYPIC AND PHENOTYPIC CHARACTERIZATION AND NEUROPATHOGENIC SHIVO, when compared to the original SHIV-4. In addition to
the lymph node, the gp120 genes isolated from the
spleen and three regions of the brain of this macaque
also had a significant number of amino acid substitu-
tions. These changes correlated well with the pheno-
typic properties of the virus isolated from the lymph
node of this macaque, which was more neutralization
resistant compared to DvpuSHIVKU-1bMC33. This neutral-
zation-resistant phenotype of the SHIV50OLNV appeared
to be broad based since this virus was not effectively
neutralized by plasmas from the other three macaques
inoculated with the same virus. This finding is some-
what different than that found for the derivation of
SHIVKU-1bMC33, which was found to be a neutralization-
esistant variant only in the context of the macaque
rom which it was derived (Narayan et al., 1999). Neu-
ralization-resistant variants have also been isolated
rom a laboratory worker that was accidentally in-
ected with the IIIB strain of HIV-1 (Reitz et al., 1994).
In previous studies on the adaptation of SHIV-4 to
T
Summary of Consensus Sequence Changes in gp120 G
No. of consensus
AA changes from
HXB2
No. of consensus AA
changes from
KU1bMC33 gp120
vpuSHIVKU-1bMC33 19 NA
50 O lymph node 34 16
50 O spleen 24 7
0 O parietal cortex 16 13
0 O basal ganglia 37 18
0 O pons 26 7
0 Y lymph node 19 0
0 Y spleen 19 0
0220 lymph node 19 0
0220 spleen 19 0
0228 lymph node 19 0
0228 spleen 19 0
Note. DNA was extracted from various lymphoid organs or regions
HIVKU1bMC33 gp120 region of env, and analyzed by DNA sequence ana
TABLE 2
Neutralization Titers of Plasma Samples Derived from Macaques
50 O, 50 Y, 20220, and 20228 against SHIV-4, DvpuSHIVKU-1bMC33, and
SHIV50OLNV
Virus
Plasma samplea
50 O 50 Y 20220 20228 a-SHIV Negative
SHIV-4 32 2 8 8 64 ,2
DvpuSHIVKU-1bMC33 64 8 16 64 64 ,2
SHIV50OLNV ,2 ,2 ,2 2 128 ,2a Plasma samples were collected at necropsy.ause disease in pig-tailed and rhesus macaques (Joag
t al., 1996; Stephens et al., 1996, 1997; Raghavan et al.,
1997), sequence analysis had revealed amino acid sub-
stitutions but no deletions in nef. Thus, the observation
that a high percentage of the nef clones isolated from
five tissues of macaque 50 O had in-frame deletions of 4
to 13 amino acids (with the 4 amino acid deletion being
predominant) is novel to the evolution of this SHIV from
the nonpathogenic SHIV-4. It was of interest that in two of
the nef clones examined, the deletions included one of
the putative SH-2 domains (Y39xxS) in SIV nef (Du et al.,
1995, 1996). The ability to amplify nef genes with such
deletions suggests that the virus can replicate effectively
in the absence of this domain. These results correlate
well with recent site-directed mutagenesis studies that
showed that the tyrosine residues at positions 28 and 39
were not important to SIV nef function (Carl et al., 2000).
solated from Macaques 50 O, 50 Y, 22020, and 22028
ge from
MC33
120
% Change from
HXB2 gp120
% Consensus
changes that
were reversions
to HXB2 gp120
No. of consensus
AA changes that
were reversions to
HXB2 gp120
A 3.7 NA NA
.1 6.7 12.5 2
.4 4.7 28.6 2
.5 3.1 61.5 8
.3 7.2 11.1 2
.4 5.1 0 0
3.7 0 0
3.7 0 0
3.7 0 0
3.7 0 0
3.7 0 0
3.7 0 0
CNS, used in nested PCR with oligonucleotides which amplified the
TABLE 3
Coreceptor Use by SHIV50OLNV
Virus
Replication in the presence of the following
coreceptor
CCR1 CCR2 CCR3 CCR5 CXCR4
SHIVKU-1bMC33 2 2 2 2 1111
DvpuSHIVKU-1bMC33 2 2 2 2 1111
SHIV50OLNV 2 2 2 2 1111
SHIV-4 2 2 2 2 111
SIVmac239 2 2 2 1111 2
Note. Ability to replicate in GHOST-CD4 cells expressing various
coreceptors. Replication was recorded as Gag production with 2,ABLE 1
enes I
% Chan
KU1b
gp
N
3
1
2
3
1
0
0
0
0
0
0,100 pg/ml; 1, 100 pg–1 ng/ml; 11, 1 to 5 ng/ml, 111, 5 to 15 ng/ml;
1111, .15 ng/ml.
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134 SINGH ET AL.The appearance of these deletions did not coincide with
the severe CD41 T cell loss in this macaque but rather
occurred later in the disease (i.e., 2 months) course in
this animal. Thus, the significance of these deletions and
whether the Nefs containing these deletions are func-
tional are unknown. The appearance of in-frame dele-
tions has also been reported for patients infected with
HIV-1 (Brambilla et al., 1999). These investigators were
able to detect small in-frame deletions of 6–15 nucleo-
tides in the nef genes isolated from both long-term non-
progressors (LTNP) as well as from progressors, al-
though they found that chimeric viruses expressing Nefs
with in-frame deletions replicated to lower titers when
compared to the same virus with an intact Nef (Brambilla
et al., 1999). Taken together, the results of the sequence
analysis indicate that in those macaques which had low
or moderate CD41 T cell loss, expansion of the viral
quasispecies swarm did not occur and the macaques
essentially controlled their infection. In contrast, se-
quence analysis of viral sequences amplified from differ-
ent tissues (lymph node, spleen, and three regions of the
brain) revealed an expansion of the viral quasispecies in
macaque 50 O, in which one or more of these viral
species was probably pathogenic for this macaque. The
expansion of the viral quasispecies in this macaque is
similar to what we found during the derivation of patho-
genic virus variants from the nonpathogenic SHIV-4 (Mc-
Cormick-Davis et al., 1998).
FIG. 5. The kinetics of viral entry for SHIV-4, DvpuSHIVKU-1MC33, and
nfectious units of each virus for various periods of time (0, 5, 15, 30, a
8 h. At 48 h, the numbers of EGFP expressing cells were quantitated
eparate experiments. SHIV-4 (E), DvpuSHIVKU-1MC33 (), and SHIV50OLNVBecause these results suggested that compensating
changes in Env and Nef may have contributed to itsincreased pathogenicity in macaque 50 O, four pig-tailed
macaques were inoculated with the virus isolated from
the lymph node (SHIV50OLNV) of this animal. Our results
ndicate that four macaques developed a severe loss of
irculating CD41 T cell levels within 2 weeks after inoc-
ulation and in three of four macaques the circulating
CD41 T cells have remained low for the first 20 weeks
ollowing inoculation, which is characteristic of other
athogenic SHIVs (Joag et al., 1996; Luciw et al., 1999;
garashi et al., 1999; Liu et al., 1999; McCormick-Davis et
l., 2000). Virus containing these deletions in nef were
pparently a major quasispecies in the SHIV50OLNV stock
(and not impaired in replication) since inoculation of
SHIV50OLNV into four additional macaques resulted in the
isolation of virus containing these nef deletions at 4
months postinoculation as well as severe CD41 T cell
oss (unpublished observations). While it is known that
IV and SIV are able to infect astrocytes in the CNS,
nfection is generally nonproductive, with only the
arly viral proteins such as Nef and Tat being ex-
ressed (Kort et al., 1998; Ludwig et al., 1999; Guille-
min et al., 2000). It is unknown if these Nef deletions
have conferred a unique structural property that may
alter signaling within the infected cell or more efficient
downregulation of CD4 from the cell surface. Whether
these in-frame deletions in Nef, with or without the
significant amino acid substitutions in Env, confer a
unique property to this virus (i.e., a neuropathogenic
LNV into GHOST cells. Cells were inoculated with a similar number of
min), washed three times to remove inoculum, and then incubated for
lotted as a function of time. The curves represent the mean of three
d SHIVKU-1bMC33 ().SHIV50O
nd 60phenotype) is currently under investigation. These re-
sults also show that SHIV50OLNV was more pathogenic
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135GENOTYPIC AND PHENOTYPIC CHARACTERIZATION AND NEUROPATHOGENIC SHIV(4 of 4 macaques with severe CD41 T cell loss to ,200
cells/ml) than the parental DvpuSHIVKU-1bMC33 (only 1 of
macaques with severe CD41 T cell loss). These
results indicate that the phenotype of DvpuSHIVKU-1bMC33
is probably one of a low pathogenic phenotype but
following inoculation of an outbred species such as
macaques (in this case macaque 50 O), unrestricted
virus replication resulted in the selection of viruses
with significant nucleotide substitutions in certain viral
genes (such as but not necessarily limited to env and
nef) that compensated for the lack of a functional Vpu.
Previous studies have suggested that the function of
FIG. 6. The levels of CD41 T cells (A) and numbers of cells produc
noculation with SHIV50OLNV.Vpu may be redundant since the Env and Nef proteins
of HIV-1 are also involved in downregulation of CD4
v
sfrom the surface of infected cells (Piquet et al., 1999).
he results from this study indicate that a functional
pu is important to the pathogenicity caused by SHIV
i.e., the severe loss of CD41 T cells within weeks after
noculation) but would suggest that the function of Vpu
s somewhat redundant and can be compensated with
mino acid substitutions in other viral proteins Env
nd Nef, both of which are involved in downregulation
f CD4 from the surface of virus-infected cells.
The results from this study demonstrate for the first time
n the SHIV/macaque model system that following inocula-
ion into macaques, the virus that enters the central ner-
ectious virus (B) in macaques AT99, AT9J, AX5H, and AX5G followingous system (CNS) is able to evolve region-specific quasi-
pecies in different regions of the brain that are apparently
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136 SINGH ET AL.different from those in lymphoid organs. The independent
evolution of virus in different regions of the brain from this
macaque shares similarities with a recent study that found
independent evolution of HIV-1 in different regions of the
brain from three patients with neuroAIDS (Shapshak et al.,
1999), although the results presented here involve the use
of a molecularly cloned virus. While it appeared that the
evolution of region-specific sequences had occurred in
macaque 50 O, there was no correlation between variation
in the five variable regions (V1–V5) of gp120 and neurolog-
ical disease in this macaque. The inability to find signature
sequence changes in the macaque with neuroAIDS agrees
with previous studies on HIV-1 isolates from AIDS dementia
patients (Donaldson et al., 1994; Reddy et al., 1996; Di
Stefano et al., 1996).
It is generally accepted that non-syncytia-inducing
(NSI) CCR5 utilizing macrophage-tropic HIV-1 probably
enters the CNS soon after infection (Zhu et al., 1993; An
and Scaravilli, 1997). However, despite presumably per-
sisting in the brain for many years without neurological
disease, infection of macrophages and microglial cells
by non-syncytia-inducing HIV-1 is considered to be in-
strumental for the development of AIDS dementia com-
plex (ADC) (Cheng-Meyer et al., 1989; Gabuzda and
Wang, 1999). The long period of time between neuroin-
vasion and onset of HIV-1-induced neurological disease
suggests that other viral and/or host factors may be
involved in the neuropathogenesis of HIV-1. The involve-
ment of T cell tropic variants, which generally evolve
during the latter stages of disease progression and at a
period when HIV-1 neurological disease occurs, has not
been well studied in relation to the neurological mani-
festations of HIV-1 infection. It is well known that T-tropic
variants of HIV-1 utilize CXCR4 as their coreceptor for
entry into susceptible cells (Berger et al., 1996, 1999;
Hoffman et al., 1998, 1999). This coreceptor is also
resent on the surface of astrocytes, microglia, and neu-
ons of the CNS (Ohtani et al., 1998; Bagetto et al., 1999;
lein et al., 1999). In a recent study, the ability of mac-
rophage-tropic (ADA, JR-FL, Bal, MS-CSF, and DJV), du-
altropic (89.6), and T-tropic (MN, IIIB, and Lai) strains of
HIV-1 to affect intracellular signaling and apoptosis of
neurons, astrocytes, and monocyte-derived macro-
phages was examined (Zheng et al., 1999). These inves-
tigators found that T-tropic strains of HIV-1 elicited the
most astrocytic and neuronal damage whereas the mac-
rophage-tropic strains produced the least neural dam-
age. These results suggest that T-tropic strains may have
an important role in the neurological disease caused by
HIV-1. The sequence analysis presented here indicates
that in one of three regions of the brain of macaque 50 O
analyzed (the parietal cortex), the majority of the amino
acid substitutions in the gp120 were reversions back to
the gp120 sequence of the parental, nonpathogenic,
T-tropic SHIV-4 virus. These results underscore the com-
plexity of the viral quasispecies evolving in the brain dfollowing inoculation with the dual-tropic SHIVKU-1bMC33.
hether the CNS represent a sanctuary for “less fit”
iruses that would normally be eliminated by neutralizing
ntibodies present outside the CNS is currently being
xamined in the SHIV/macaque model. Precedent for
his comes from the SIVmac/macaque model, in which
himeric virus constructed with the env isolated from the
rain of a macaque with severe encephalitis was highly
ensitive to antibody-mediated neutralization and not as
athogenic (Joag et al., 1995; Zhu et al., 1997).
MATERIALS AND METHODS
ells, plasmids, and viruses
C8166 cell line was used as the indicator cells to
easure infectivity and cytopathicity of the viruses used
n this study. C8166 cells were maintained in RPMI 1640,
upplemented with 10 mM HEPES buffer, pH 7.3, 2 mM
lutamine, 50 mg/ml gentamicin, and 10% fetal bovine
serum (R10FBS). The derivation of SHIVKU-1b and
vpuSHIVKU-1bMC33 has been previously described
(Narayan et al., 1999; McCormick-Davis et al., 2000).
Macaques analyzed in this study
Two pig-tailed macaques (50 O and 50 Y) were inoc-
ulated intravenously with 1 ml of undiluted supernatant
from C8166-grown stocks of DvpuSHIVKU-1bMC33 containing
approximately 104 TCID50/ml as previously described
McCormick-Davis et al., 2000). Macaque 50 O devel-
ped severe CD41 T cell loss and signs of neuroAIDS at
5 weeks postinoculation whereas macaque 50 Y devel-
ped moderate CD41 T cell loss and was euthanized at
Week 39 postinoculation in apparent good health. Two
additional macaques (20220 and 20228) were subse-
quently inoculated with the same virus stock and devel-
oped no significant loss of CD41 T cells over the course
f 6-month study period. At 8 months, these macaques
ere euthanized in good health and tissues examined
or virus content.
Four pig-tailed macaques (AT99, AT9J, AX5H, and
X5G) were inoculated intravenously with approximately
04 TCID50 of SHIV50OLNV grown in macaque PBMC. Blood
as collected weekly in EDTA for the first 4 weeks, then
t 2-week intervals for the next months, and thereafter at
onthly intervals. All aspects of the animal studies were
erformed according to the institutional guidelines of
nimal care and use at University of Kansas Medical
enter and the Oregon Regional Primate Research
enter.
CR amplification and sequence analysis of tat, rev,
pu, env, and nef sequences
Because previous studies indicated that the majority
of the sequence changes occurred in env and nef genes
uring the derivation of a pathogenic SHIV from non-
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uences of this virus with the sequences from the mo-
ecularly cloned DvpuSHIVKU-1bMC33 and original nonpatho-
enic SHIV-4. Visceral organs and various regions of the
NS were collected and DNA was extracted as previ-
usly described (McCormick-Davis et al., 2000). For anal-
sis of vpu and gp120 sequences, oligonucleotide prim-
ers 59-CCTAGACTAGAGCCCTGGAAGCATCC-39 and 59-
GTGCTTCCTGCTGCTCCCAAGAACCC-39 were used,
hich are complementary to nucleotides 5845 and 5870
nd 7781 to 7810 of the HIV-1 (HXB2) genome (Ratner et
l., 1985), respectively. One microgram of genomic DNA
as used in the PCR (Saiki et al., 1985, 1988) containing
.4 mM MgSO4, 200 mM each of the four deoxynucleotide
triphosphates, 100 pM of each oligonucleotide primer
and a mixture of Taq and Pyrococcus species GB-D
olymerases (Elongase, GibcoBRL). The template was
enatured at 94°C for 2 min and PCR amplification per-
ormed with an automated DNA Thermal Cycler (Perkin-
lmer Cetus) for 35 cycles using the following profile:
enaturation at 94°C for 30 s, annealing at 65°C for 1
in, and primer extension at 68°C for 5 min. Amplifica-
ion was completed by incubation for 10 min at 68°C.
hree separate PCRs were performed for each region of
iral genome that was studied. The amplified products
rom three separate reactions were separated by elec-
rophoresis in a 1% agarose gel, isolated, and molecu-
arly cloned into the pGEM-T Easy vector according to
he manufacturer’s instructions. Cycle sequencing reac-
ions using the BigDye Terminator cycle sequencing
eady Reaction Kit with AmpliTaq DNA polymerase, FS
PE Applied Biosystems, Foster City, CA) and sequence
etection was conducted with an Applied Biosystems
77 Prism XL automated DNA sequencer and visualized
sing the ABI Editview program.
For amplification of nef, oligonucleotide primers 59-
CACATACCTAGAAGAATAAGACAGGG-39 (sense) and
9-ACATCCCCTTGTGGAAAGTCCCTGCTGTTT-39 (anti-
ense) were used, which are complementary to nucleo-
ides 8746 to 8772 of the HIV-1 (HXB2) genome (Ratner et
l., 1985) and 9868 to 9898 of the SIVmac239 genome
(Regier and Desrosiers, 1990), respectively. The condi-
tions for amplification, cloning, and sequencing of the
PCR products were the same as described above.
Virus neutralization assays
To more easily analyze the neutralization properties of
SHIV variants, we constructed a SHIV-based virus that
expressed the enhanced green fluorescent protein
(Zhang et al., 1996; Lee et al., 1997; Alexander et al.,
1999). In order to relieve the packing constraints caused
by the insertion of EGFP into SHIV, we first deleted the
nonessential vpu sequences prior to the initiation codon
of Env. A unique NsiI site was introduced at the AUG of
Vpu in the plasmid ptrvSHIVKU-1bMC33 (McCormick-Davis etal., 2000) using the Quick Change site-directed mutagen-
esis kit (Stratagene) with the primer 59-GCAGTAAGTAG-
TACATGTAATGCATCCTATACCAATAGTAGCAATAG-39
and its complement 59-CTATTGCTACTATTGGTATAGGAT-
GCATTACATGTACTACTTACTGC-39 according to the
manufacturer’s directions. The resulting plasmid was di-
gested with NsiI and BbsI to release a 155-bp fragment,
treated with Klenow, and ligated. The ligated product
was used to transform E. coli (strain XL-1) and a plasmid
was selected for the absence of a NsiI site. This plasmid
was digested with SphI and KpnI and purified by elec-
trophoresis in a 1% agarose gel and extracted through
a Millipore column. The 380-bp fragment was ligated
into p39SHIVKU-1bMC33, which was also digested with
SphI and KpnI to release a 535-bp fragment. The
ligated product was used to transform E. coli (strain
XL-1) and plasmids were selected for a 380-bp frag-
ment when digested with SphI and KpnI. In the result-
ing plasmid, p39novpuSHIVKU-1bMC33, 155 bp of vpu prior
to env has been deleted without disrupting the initia-
tion AUG of Env. A NcoI site was introduced at the 39
end of the EGFP gene in the plasmid pEGFP (Clon-
tech), using the Quick Change site-directed mutatgen-
esis kit (Stratagene) with primer 59-GCCGGTCGCTAC-
CATGGCCAACTTGTCTGGTG-39 and its complement
59-CACCAGACAAGTTGGCCATGGTAGCGACCGGC-39.
A plasmid was selected for the presence of two NcoI
sites, as there is already a NcoI site located in the
multicloning region of pEGFP. This plasmid was then
subjected to another mutagenesis step, using primer
59-GGTCGCCACCATGGATGAGCAAGGGCG-39 and its
complement 59-CGCCCTTGCTCATCCATGGTGGCGACC-39
to introduce an additional adenosine such that the read-
ing frame of the EGFP gene would be conserved when
introduced into p39novpuSHIVKU-1bMC33. The resulting plas-
id was then digested with NcoI to release a 769-bp
ragment consisting of the EGFP gene. This fragment
as ligated into p39novpuSHIVKU-1bMC33 which had also
been digested with NcoI. There is a unique NcoI site
located within the nef gene. The ligated product was
transformed into E. coli (strain XL-1). A plasmid,
p39novpuSHIVEGFP, was selected for the presence of a
769-bp fragment when digested with NcoI. All plasmids
were sequenced at each step to verify the site-directed
mutagenesis. In order to generate virus, the plasmids
p59SHIV-4 and p39novpuSHIVEGFP were digested with
SphI, ligated using T4 DNA ligase (NEB), and transfected
into C8166 cells by the DEAE-dextran method (Milman
and Herzberg, 1981). Stocks were prepared and titered in
C8166 cells. Despite multiple passages, the expression
of the EGFP marker protein was found to be stable.
In order to compare the ability of various gp120s to be
neutralized by serum from macaques 50 O and 50 Y, we
generated a series of interviral recombinants in which
sequenced gp160 genes from SHIV-4 (HXB2) and a rep-
resentative env clone from the lymph node and parietal
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138 SINGH ET AL.cortex were inserted into the p39novpuSHIVEGFP. The
p160 clones were digested with KpnI and RsrII, and the
nv gene was purified and inserted into the same sites of
he p39novpuSHIVEGFP. The resulting plasmids,
p39novpuSHIV-4EGFP and p39novpuSHIV50OLNVEGFP were
used to generate virus stocks as described above. The
viruses, SHIV-4EGFP and SHIV50OLNEGFP, were used in neu-
ralization assays described below.
A standard neutralization assay method was used with
8166 cells as the indicator cell type (Joag et al., 1993).
ll four macaques developed robust antibody responses
o the viral Env as determined by immune precipitation
ssays (data not shown). Serial twofold dilutions of
lasma in RPMI 1640 medium were prepared in quadru-
licate in 96-well plates, 100 TCID50 of each virus was
added to each well, and samples were incubated for
1.5 h at 37°C. Following this incubation, 1 3 104 indicator
cells (in 100 ml) were added to each well and cultures
incubated at 37°C incubator in 5% CO2 for 7 days. Cul-
ures were observed daily by phase-contrast microscopy
or development of syncytial cytopathic effects (CPE) and
y fluorescence microscopy for expression of EGFP. We
ound that there was a perfect correlation between the
resence of CPE and the expression of EGFP by fluores-
ence microscopy. That is, in the absence of virus neu-
ralization (as evidenced by the presence of CPE), EGFP
xpression was readily detected, and vice versa. The
0% neutralization end point was calculated using the
a¨rber method (Lennette, 1969). The pooled plasma from
everal macaques that were infected with SHIV-4 for
ver 1 year was used as a positive control. This serum
ad a neutralization titer of 1:64 against SHIVKU-1bMC33 and
a titer of 1:64 against SHIV-4 in C8166 cells. Plasma from
an SHIV-seronegative macaque (NRP) was used as neg-
ative control in all the neutralization assays.
Viral entry assays
We determined if the coreceptor use of SHIV50OLNV was
imilar to the parental virus used to inoculate macaque
0 O or if its coreceptor had been altered with changes
n Env. Use of CXCR4, CCR5, CCR3, CCR2b, and CCR1
oreceptors was determined using human osteosar-
oma (GHOST)-CD4 cells expressing individual corecep-
ors as previously described (Zhang et al., 2000). In all
ases, the levels of p27 Gag in the culture supernatants
f GHOST-CD4 cells transfected with various corecep-
ors were subtracted from that produced from control
HOST-CD4 cells.
The kinetics of virus entry of different strains of SHIV,
HIV-4, DvpuSHIVKU-1bMC33, and SHIV50OLNV were deter-
ined using human osteosarcoma cells (GHOST)-CD4
ells expressing CXCR4, obtained from the AIDS Re-
earch and Reference Reagents Program (Division of
IDS, National Institutes of Allergy and Infectious Dis-
ases, National Institutes of Health, from Nathaniel Bandau). Virus stocks were first titrated on GHOST-
D4/X4 cells by preparing a series of threefold dilutions
ollowed by inoculation of cells in 96-well plates. Cells
ere then incubated for 48 h and cultures examined for
he expression of green fluorescent protein (GFP) as
reviously described (Lee et al., 1997). For kinetic as-
ays, cells grown in 6-well plates were inoculated with
irus for various periods of time (0, 5, 15, 30, and 60 min),
ashed three times to remove any unbound virus inoc-
lum, and then incubated at 37°C for 48 h. At 48 h, the
ells were examined under a Nikon Ophiphot inverted
hase microscope equipped with an Optronics Mag-
afire imaging system. The number of fluorescent cells
er field (using the 20X objective; 5 fields examined) was
numerated, and the average taken and then plotted as
function of time. Presented are the average of triplicate
xperiments.
rocessing of blood and tissue samples
The peripheral blood mononuclear cells (PBMC) were
repared by centrifugation on Ficoll-Hypaque gradients
s described previously (Joag et al., 1996). Tenfold dilu-
tions of PBMC (106 cells/ml) were inoculated into repli-
ate cultures of C8166 cells in 24-well plates and the
ocultures examined for development of cytopathic ef-
ects as previously described (McCormick-Davis et al.,
2000). Infectivity titers in plasma were reported as
TCID50/ml and cells producing infectious cytopathic virus
n the blood reported as the number of infected cells/106
PBMC. Alterations in CD41 and CD81 T lymphocytes
fter experimental inoculations were monitored sequen-
ially by FACS analysis (Becton Dickinson). T lymphocyte
ubsets were labeled with OKT4 (CD4; Ortho Diagnos-
ics Systems, Inc.), B9.11 (CD8, Coulter Immunology), and
P34 (CD3; Pharmingen) or FN18 (CD3; Biosource Inter-
ational) monoclonal antibodies.
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